KemPharm (KMPH) Misses Q4 EPS by 14c
Tweet
Share
E-mailGet Alerts KMPH Hot Sheet
Join SI Premium – FREE
KemPharm (NASDAQ: KMPH) reported Q4 EPS of ($0.64), $0.14 worse than the analyst estimate of ($0.50).
For earnings history and earnings-related data on KemPharm (KMPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- SanDisk upgraded at JPMorgan after investor day; shares climb
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
